Advances in organic electronics have allowed UK-based Novalia to
develop a proprietary technology for circuit printing on packaging
- using conventional printing equipment - which can be used to
identify when a package has been tampered...
Finnish company DelSitech has signed a license agreement with Bayer
Innovation, a subsidiary of the Germany's Bayer group, in a deal
that could lead to the creation of a new generation of wound care
Biopharmaceutical firm Nektar has agreed to fork out $25m (€20m) to
settle a patent lawsuit by the University of Alabama in Huntsville
(UAH) concerning the company's PEGylation delivery technology
currently used in eight approved...
A collaboration between Anachem and chemists within the
pharmaceutical industry has resulted in the launch of the new
ReactArray Solo, which is designed to provide faster, more
efficient polymorph screening to aid drug patent protection...
Celsis International has signed a collaboration with BioVentures to
develop a microarray-based microbiological testing system to detect
contamination in pharmaceutical, biotechnology and other process
The US Supreme Court's decision as to how much a patent can
restrict research conducted by another company is a question that
is certain to affect the way innovative new drugs are researched
India's new patent law, that will prevent domestic pharmaceutical
manufacturers from making low-cost generic copies of in-patent
drugs - has finally been passed by the lower house of the country's
parliament, writes Phil...
BioPartners, currently leading the line amongst companies trying to
bring copies of off-patent biologic drugs to the European market,
has licensed a needle-free delivery technology for its human growth
hormone (hGH) product.
With just a few weeks to go before the introduction of India's new
patent regime - which will increase protection to include product
as well as process patents - a group of government Ministers is
calling for a waiver that would...